VTVT
vTv Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$33.35
−0.36%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 395.59x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.68x
- Price / sales
- 3.58x
- Price / cash flow
- -7.87x
Enterprise value
- Enterprise value
- $45.2M
- EV / sales
- 1.23x
- EV / EBITDA
- -7.08x
- EV / EBIT
- -4.89x
- Market cap
- $131.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026